中东和非洲血液筛查市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

中东和非洲血液筛查市场 – 行业趋势和 2029 年预测

  • Healthcare
  • Upcoming Report
  • Feb 2022
  • MEA
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Middle East Africa Blood Screening Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Enzo Biochem
  • Meridian Bioscience
  • BD
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific

>中东和非洲血液筛查市场,按产品和服务(试剂和试剂盒、仪器、软件和服务)、技术(核酸检测、酶联免疫吸附测定、快速检测、蛋白质印迹测定、下一代测序等)、疾病类型(呼吸系统疾病、糖尿病、肿瘤学、胆固醇、艾滋病毒/艾滋病、感冒和流感、传染病等)、最终用户(诊断中心、血库、医院、诊所、门诊手术中心)、国家(沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)划分的行业趋势和预测(至 2029 年)

中东和非洲血液筛查市场

血液筛查市场的市场分析和见解

Data Bridge Market Research 分析称,到 2029 年,血液筛查市场规模将达到 8.7 亿美元,在 2021-2029 年的预测期内,复合年增长率为 8.85%。患者对为重病患者献血的重要性的认识不断提高,这将有助于血液筛查市场的增长。

血液筛查的目的是检测感染标志物,以避免将受感染的血液和血液成分用于临床。血液筛查策略旨在确保血液单位的安全;但是,不应将其用于通知献血者反应性检测结果。在通知献血者其感染状况之前,应使用适当的献血者管理确认检测策略。在最终决定是否释放血液单位用于治疗用途时,应考虑对 TTI 感染标志物和血型血清学进行的所有检测结果。

预计在 2022-2029 年的预测期内,新病原体的出现、先进技术开发投资率的提高、老年人口的增长以及政府有利的血液筛查政策将推动血液筛查市场的增长。另一方面,医疗保健行业的不断扩大,加上技术创新的不断增加,将带来无数机会,从而导致预测期内血液筛查市场的增长。

然而,在预测期内,与血液采样相关的高成本可能会阻碍血液筛查市场的增长。

本医疗保险市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关医疗保险市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

Middle East and Africa Blood Screening Market Scope and Market Size

Blood screening market is segmented on the basis of products and services, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product and services segment, the blood screening market is segmented into reagents and kits, instruments and software and services. Reagents and kits are further sub segmented into NAT reagents and kits, ELISA reagents and kits others as well. NAT reagents is further sub segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labelling and detection reagents. ELISA reagents and kits is further sub segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments and purchase type.
  • On the basis of technology the blood screening market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA Market, By Platform is further sub segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI).ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above.
  • On the basis of disease type segment, the blood screening market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold and flu, infectious diseases and others.
  • The end user segment in the blood screening market is segmented into diagnostic centers, blood bank, hospitals, clinics and ambulatory surgical centers.

Blood Screening Market Country Level Analysis

The blood screening market is analysed and market size insights and trends are provided by country, products and services, technology, disease type and end user as referenced above.

The countries covered in the medical insurance market report are Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa

由于公众对献血的认识提高、患者负担能力提高以及主要行业参与者对该地区新兴市场的关注度不断提高,预计中东和非洲在预测期内将实现增长。沙特阿拉伯、阿拉伯联合酋长国、埃及和以色列是中东和非洲的主要贡献者。

医疗保险市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和数量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

医疗保险市场还为您提供每个国家/地区资本设备医疗支出增长、数字医疗技术市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对医疗保险市场的影响的详细市场分析。数据涵盖 2010 年至 2020 年的历史时期。

竞争格局和血液筛查市场份额分析

医疗保险市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对医疗保险市场的关注有关。

医疗保险市场报告中涉及的主要参与者包括 Enzo Biochem Inc.、Meridian Bioscience, Inc.、BD、Bio-Rad Laboratories, Inc.、Thermo Fisher Scientific Inc.、BioMérieux SA、Beckman Coulter, Inc.、Abbott、F. Hoffmann-La Roche Ltd、Cepheid、GRIFOLS INTERNATIONAL, SA、Siemens AG、Ortho Clinical Diagnostics、Immucor, Inc.、Hologic Inc. 以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Middle East and Africa Blood Screening Market size will be worth USD 0.87 billion by 2029.
The Middle East and Africa Blood Screening Market growth rate will be 8.85% by 2029.
The emergence of new pathogens, rising investment rates for advanced technology development, a growing geriatric population, and favourable government blood screening policies are the growth drivers of the Middle East and Africa Blood Screening Market.
The products and services, technology, disease type and end user are the factors on which the Middle East and Africa Blood Screening Market research is based.
The major companies in the Middle East and Africa Blood Screening Market are Enzo Biochem Inc., Meridian Bioscience, Inc., BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., BioMérieux SA, Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc